AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 2 cutMore adding
Key stats
Fundamentals Sep 30- Open
- $70.93
- 52-wk high
- $83.34
- High
- $72.36
- 52-wk low
- $51.33
- Low
- $70.44
- Prev close
- $71.43
- Mkt cap
- $33.97B
- P/E
- 14.4x
- Volume
- 1.76M
- Fwd P/E
- 14.8x
- Beta
- 1.08
- Div yield
- 3.07%
- P/S
- 1.2x
- P/B
- 1.4x
- Profit margin
- +8.7%
- Op margin
- +17.5%
- ROE
- +9.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about NTR filings
Are insiders buying or selling Nutrien Ltd (NTR) stock?
Neither. Nutrien Ltd (NTR) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded NTR recently?
None. No member of Congress disclosed a NTR trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this NTR smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (1)
- DS
D.E. Shaw
$56.6M
added
Sells/Trims (2)
- CI
Citadel
$67.2M
trimmed
- P7
Point72
$48.3M
trimmed
How top traders are positioned
No tracked top-trader positions in NTR right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 3.9% above what analysts expected.
Earnings per share
$2.57 expected
Reports Nov 4, 2026, in 34 days
Estimates as of Oct 1, 2026
EPS expected
$0.63 to $1.19
Revenue expected
7 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.01B | $5.34B | $6.05B | $10.81B |
| Cost of what it sold | $4.04B | $3.45B | $4.40B | $7.56B |
| Gross profit | $1.96B | $1.89B | $1.65B | $3.25B |
| What it spent | ||||
| Sales and admin | $178.0M | $208.0M | $278.0M | $140.0M |
| Other operating costs | $909.0M | $909.0M | $861.0M | $1.12B |
| Total operating expenses | $1.09B | $1.12B | $1.14B | $1.26B |
| What was left | ||||
| Operating profit | $877.0M | $771.0M | $507.0M | $1.99B |
| Interest on debt | $170.0M | $225.0M | $176.0M | $173.0M |
| Profit before tax | $637.0M | $738.0M | $184.0M | $1.60B |
| Tax | $168.0M | $158.0M | $45.0M | $382.0M |
| Net profit | $464.0M | $571.0M | $131.0M | $1.21B |
| EBITDA | $1.42B | $1.53B | $966.0M | $2.38B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace